Key Research Findings
Results from our clinical trials and published studies.
Stress Reduction Trial (2024)
A randomized controlled trial with 1,200 participants showed that AuraWave users experienced a 47% average reduction in perceived stress levels over 8 weeks, compared to 12% in the control group. Published in the Journal of Behavioral Medicine.
HRV Improvement Study (2024)
A 12-week longitudinal study demonstrated that consistent AuraWave use increased resting HRV by an average of 23%, indicating improved autonomic nervous system balance and stress resilience. Participants showed measurable improvement within the first 2 weeks.
Sleep Quality Research (2023)
Clinical sleep lab study with 800 participants found that AuraWave users fell asleep 31 minutes faster on average and experienced 22% more deep sleep. Results were consistent across age groups 25-65.
Sensor Accuracy Validation (2024)
Independent laboratory testing confirmed AuraWave's PPG sensor achieves 99.2% correlation with clinical-grade ECG monitors for heart rate measurement, and 97.8% accuracy for HRV calculation.
Long-Term Adherence Study (2023)
A 6-month follow-up study found that 89% of AuraWave users continued wearing the device daily, compared to industry average of 34% for fitness wearables. Users cited Auto Stress Relief as the primary reason for continued use.